litlas
ログインアカウント作成

Eric P. Krenning

1982–2025 年に発表

別表記
Eric P Krenning
122
論文数
30,330
被引用数
97
h 指数
121
i10 指数

被引用数

Eric P. Krenning の年別被引用数1977 年: 被引用 1 件1984 年: 被引用 3 件1988 年: 被引用 1 件1989 年: 被引用 2 件1990 年: 被引用 3 件1991 年: 被引用 3 件1992 年: 被引用 14 件1993 年: 被引用 30 件1994 年: 被引用 33 件1995 年: 被引用 26 件1996 年: 被引用 22 件1997 年: 被引用 19 件1998 年: 被引用 41 件1999 年: 被引用 57 件2000 年: 被引用 57 件2001 年: 被引用 74 件2002 年: 被引用 122 件2003 年: 被引用 146 件2004 年: 被引用 167 件2005 年: 被引用 212 件2006 年: 被引用 156 件2007 年: 被引用 204 件2008 年: 被引用 194 件2009 年: 被引用 216 件2010 年: 被引用 318 件2011 年: 被引用 255 件2012 年: 被引用 223 件2013 年: 被引用 229 件2014 年: 被引用 192 件2015 年: 被引用 215 件2016 年: 被引用 167 件2017 年: 被引用 272 件2018 年: 被引用 311 件2019 年: 被引用 823 件2020 年: 被引用 946 件2021 年: 被引用 846 件2022 年: 被引用 593 件2023 年: 被引用 450 件2024 年: 被引用 767 件2025 年: 被引用 270 件1978〜1983 年は被引用が無いため表示していません1985〜1987 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,499 件、この内訳の 20.3%ドイツ: 引用元論文 719 件、この内訳の 9.7%イタリア: 引用元論文 599 件、この内訳の 8.1%オランダ: 引用元論文 590 件、この内訳の 8%イギリス: 引用元論文 463 件、この内訳の 6.3%フランス: 引用元論文 390 件、この内訳の 5.3%スイス: 引用元論文 373 件、この内訳の 5%スウェーデン: 引用元論文 272 件、この内訳の 3.7%中国: 引用元論文 259 件、この内訳の 3.5%カナダ: 引用元論文 236 件、この内訳の 3.2%オーストラリア: 引用元論文 174 件、この内訳の 2.3%スペイン: 引用元論文 154 件、この内訳の 2.1%
0%20.3%その他 22.5%

機関

分野

  • Medicine88.9%
  • Biochemistry, Genetics and Molecular Biology5.5%
  • Neuroscience1.7%
  • Materials Science0.7%
  • Engineering0.7%
  • Environmental Science0.6%
  • その他1.9%

トピック

  • Neuroendocrine Tumor Research Advances17.5%
  • Lung Cancer Research Studies10.5%
  • Radiopharmaceutical Chemistry and Applications8.9%
  • Neuroblastoma Research and Treatments7.3%
  • Medical Imaging Techniques and Applications3.1%
  • Thyroid Cancer Diagnosis and Treatment2.7%
  • その他50%

共著者

全論文

検索で開く
  1. Phase 3 Trial of 177 Lu-Dotatate for Midgut Neuroendocrine Tumors

    著者: Jonathan Strosberg, Ghassan El‐Haddad, Edward M. Wolin, Andrew Hendifar, James C. Yao, Beth Chasen, Erik Mittra, Pamela L. Kunz, Matthew H. Kulke, Heather A. Jacene, David Bushnell, Thomas M. O’Dorisio, Richard P. Baum, Harshad Kulkarni, Martyn Caplin, Rachida Lebtahi, Timothy J. Hobday, Ebrahim S. Delpassand, Eric Van Cutsem, Al B. Benson, Rajaventhan Srirajaskanthan, Marianne Pavel, Jaime Font de Mora, Jordan Berlin, Enrique Grande, Nicholas S. Reed, Ettore Seregni, Kjell Öberg, Maribel Lopera Sierra, Paola Santoro, Thomas Thevenet, Jack L. Erion, Philippe Ruszniewski, Dik J. Kwekkeboom, Eric P. Krenning - New England Journal of Medicine 2017 被引用: 3,178

  2. 177Lu-Dotatate plus long-acting octreotide versus high‑dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial

    著者: Jonathan R Strosberg, Martyn E Caplin, Pamela L Kunz, Philippe B Ruszniewski, Lisa Bodei, Andrew Hendifar, Erik Mittra, Edward M Wolin, James C Yao, Marianne E Pavel, Enrique Grande, Eric Van Cutsem, Ettore Seregni, Hugo Duarte, Germo Gericke, Amy Bartalotta, Maurizio F Mariani, Arnaud Demange, Sakir Mutevelic, Eric P Krenning - The Lancet Oncology 2021 被引用: 541

  3. Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0,Tyr3]octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors

    著者: Tessa Brabander, Wouter A. van der Zwan, Jaap J.M. Teunissen, Boen L.R. Kam, Richard A. Feelders, Wouter W. de Herder, Casper H.J. van Eijck, Gaston J H Franssen, Eric P. Krenning, Dik J. Kwekkeboom - Clinical Cancer Research 2017 被引用: 604

  4. Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate in the Phase III NETTER-1 Trial

    著者: Jonathan Strosberg, Edward M. Wolin, Beth Chasen, Matthew H. Kulke, David Bushnell, Martyn Caplin, Richard P. Baum, Pamela L. Kunz, Timothy J. Hobday, Andrew Hendifar, Kjell Öberg, Maribel Lopera Sierra, Thomas Thevenet, Inés Margalet, Philippe Ruszniewski, Eric P. Krenning, on behalf of the NETTER-1 Study Group - Journal of Clinical Oncology 2018 被引用: 389

  5. Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors

    著者: Lisa Bodei, Mark Kidd, Giovanni Paganelli, Chiara Maria Grana, Ignat Drozdov, Marta Cremonesi, Christopher Lepensky, Dik J. Kwekkeboom, Richard P. Baum, Eric P. Krenning, Irvin M. Modlin - European Journal of Nuclear Medicine and Molecular Imaging 2014 被引用: 466

  6. Treatment With the Radiolabeled Somatostatin Analog [ 177 Lu-DOTA 0 ,Tyr 3 ]Octreotate: Toxicity, Efficacy, and Survival

    著者: Dik J. Kwekkeboom, Wouter W. de Herder, Boen L.R. Kam, Casper H.J. van Eijck, Martijn van Essen, P.P.M. Kooij, Richard A. Feelders, Maarten O. van Aken, Eric P. Krenning - Journal of Clinical Oncology 2008 被引用: 1,447

  7. Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids

    著者: M. Caplin, Éric Baudin, Piero Ferollà, Pier Luigi Filosso, Mariano Garcı́a-Yuste, Eric Lim, Kjell Öberg, Giuseppe Pelosi, Aurel Perren, Roberta Rossi, William D. Travis, D.K. Bartsch, Jaume Capdevila, Frederico Costa, Jarosław B. Ćwikła, Wouter W. de Herder, Gianfranco Delle Fave, Barbro Eriksson, Massimo Falconi, Diego Ferone, David J. Gross, Ashley Grossman, Tetsuhide Ito, Robert T. Jensen, Gregory Kaltsas, Fahrettin Keleştimur, Réza Kianmanesh, Ulrich Knigge, Beata Kos‐Kudła, Eric P. Krenning, Emmanuel Mitry, M. Nicolson, Juan Manuel O’Connor, Dermot O’Toole, Ulrich-Frank Pape, Marianne Pavel, John Ramage, Éric Raymond, Guido Rindi, Andrea Rockall, Philippe Ruszniewski, Ramón Salazar, Aldo Scarpa, Eva Sedláčková, Anders Sundin, Christos Toumpanakis, Marie‐Pierre Vullierme, Wolfgang Weber, Bertram Wiedenmann, Zeng Zheng-Pei - Annals of Oncology 2015 被引用: 699

  8. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Peptide Receptor Radionuclide Therapy with Radiolabelled Somatostatin Analogues

    著者: Rodney J. Hicks, Dik J. Kwekkeboom, Eric P. Krenning, Lisa Bodei, Simona Grozinsky‐Glasberg, Rudolf Arnold, Ivan Borbath, Jarosław B. Ćwikła, Christos Toumpanakis, Gregory Kaltsas, Philippa Davies, Dieter Hörsch, Eva Tiensuu Janson, John Ramage, all other Antibes Consensus Conference participants - Neuroendocrinology 2017 被引用: 331

  9. Gastroenteropancreatic neuroendocrine tumours

    著者: Irvin M. Modlin, Kjell Öberg, Daniel C. Chung, Robert T. Jensen, Wouter W. de Herder, Rajesh V. Thakker, Martyn Caplin, Gianfranco Delle Fave, Gregory Kaltsas, Eric P. Krenning, Steven F. Moss, Ola Nilsson, Guido Rindi, Ramón Salazar, Philippe Ruszniewski, Anders Sundin - The Lancet Oncology 2008 被引用: 1,752

  10. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging

    著者: Anders Sundin, Rudolf Arnold, Éric Baudin, Jarosław B. Ćwikła, Barbro Eriksson, Stefano Fanti, Nicola Fazio, Francesco Giammarile, Rodney J. Hicks, Andreas Kjær, Eric P. Krenning, Dik J. Kwekkeboom, Catherine Lombard‐Bohas, Juan Manuel O’Connor, Dermot O’Toole, Andrea Rockall, Bertram Wiedenmann, Juan W. Valle, Marie‐Pierre Vullierme, all other Antibes Consensus Conference participants - Neuroendocrinology 2017 被引用: 497

  11. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Peptide Receptor Radionuclide Therapy with Radiolabeled Somatostatin Analogs

    著者: Dik J. Kwekkeboom, Eric P. Krenning, Rachida Lebtahi, Paul Komminoth, Beata Kos‐Kudła, Wouter W. de Herder, Ursula Plöckinger - Neuroendocrinology 2009 被引用: 349

  12. ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary

    著者: Marianne Pavel, Éric Baudin, Anne Couvelard, Eric P. Krenning, Kjell Öberg, Thomas Steinmüller, Martin Anlauf, Bertram Wiedenmann, Ramón Salazar - Neuroendocrinology 2012 被引用: 870

  13. Subacute haematotoxicity after PRRT with 177Lu-DOTA-octreotate: prognostic factors, incidence and course

    著者: Hendrik Bergsma, Mark Konijnenberg, Boen L.R. Kam, Jaap J.M. Teunissen, P.P.M. Kooij, Wouter W. de Herder, Gaston J H Franssen, Casper H.J. van Eijck, Eric P. Krenning, Dik J. Kwekkeboom - European Journal of Nuclear Medicine and Molecular Imaging 2015 被引用: 179

  14. Persistent Hematologic Dysfunction after Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE: Incidence, Course, and Predicting Factors in Patients with Gastroenteropancreatic Neuroendocrine Tumors

    著者: Hendrik Bergsma, Kirsten van Lom, Marc H.G.P. Raaijmakers, Mark Konijnenberg, Boen L. Kam, Jaap J.M. Teunissen, Wouter W. de Herder, Eric P. Krenning, Dik J. Kwekkeboom - Journal of Nuclear Medicine 2017 被引用: 135

  15. Nephrotoxicity after PRRT with 177Lu-DOTA-octreotate

    著者: Hendrik Bergsma, Mark Konijnenberg, Wouter A. van der Zwan, Boen L.R. Kam, Jaap J.M. Teunissen, P.P.M. Kooij, Katya Mauff, Eric P. Krenning, Dik J. Kwekkeboom - European Journal of Nuclear Medicine and Molecular Imaging 2016 被引用: 174

  16. Theranostic Perspectives in Prostate Cancer with the Gastrin-Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results

    著者: Berthold A. Nock, Aikaterini Kaloudi, Emmanouil Lymperis, Athina Giarika, Harshad Kulkarni, Ingo Klette, Aviral Singh, Eric P. Krenning, Marion de Jong, Θεοδοσία Μάινα, Richard P. Baum - Journal of Nuclear Medicine 2016 被引用: 167

  17. Phase I study of peptide receptor radionuclide therapy with [111In-DTPA0]octreotide: The rotterdam experience

    著者: Roelf Valkema, Marion de Jong, Willem H. Bakker, Wout A. P. Breeman, P.P.M. Kooij, Pieternella J. Lugtenburg, Frank H. de Jong, Arjan Christiansen, Boen L.R. Kam, Wouter W. de Herder, Mats Stridsberg, Jan Lindemans, Geert Ensing, Eric P. Krenning - Seminars in Nuclear Medicine 2002 被引用: 433

  18. PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETest

    著者: Lisa Bodei, Mark Kidd, Aviral Singh, Wouter A. van der Zwan, Stefano Severi, Ignat Drozdov, Anna Malczewska, Richard P. Baum, Dik J. Kwekkeboom, Giovanni Paganelli, Eric P. Krenning, Irvin M. Modlin - European Journal of Nuclear Medicine and Molecular Imaging 2019 被引用: 105

  19. Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate

    著者: Flavio Forrer, Eric P. Krenning, P.P.M. Kooij, Bert F. Bernard, Mark Konijnenberg, Willem H. Bakker, Jaap J.M. Teunissen, Marion de Jong, Kirsten van Lom, Wouter W. de Herder, Dik J. Kwekkeboom - European Journal of Nuclear Medicine and Molecular Imaging 2009 被引用: 207

  20. Neoadjuvant Treatment of Nonfunctioning Pancreatic Neuroendocrine Tumors with [ 177 Lu-DOTA 0 ,Tyr 3 ]Octreotate

    著者: Esther I. van Vliet, Casper H.J. van Eijck, Ronald R. de Krijger, E J Nieveen van Dijkum, Jaap J.M. Teunissen, Boen L. Kam, Wouter W. de Herder, Richard A. Feelders, Bert A. Bonsing, Tessa Brabander, Eric P. Krenning, Dik J. Kwekkeboom - Journal of Nuclear Medicine 2015 被引用: 122

  21. Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study

    著者: on behalf of the NETTER-1 study group, Jonathan Strosberg, Pamela L. Kunz, Andrew Hendifar, James C. Yao, David Bushnell, Matthew H. Kulke, Richard P. Baum, Martyn Caplin, Philippe Ruszniewski, Ebrahim S. Delpassand, Timothy J. Hobday, Chris Verslype, Al B. Benson, Rajaventhan Srirajaskanthan, Marianne Pavel, Jaume Mora, Jordan Berlin, Enrique Grande, Nicholas S. Reed, Ettore Seregni, Giovanni Paganelli, Stefano Severi, Michael Morse, David C. Metz, C. Ansquer, F. Courbon, Adil Al‐Nahhas, Eric Baudin, Francesco Giammarile, David Taïeb, Erik Mittra, Edward M. Wolin, Thomas M. O’Dorisio, Rachida Lebtahi, Christophe M. Deroose, Chiara Maria Grana, Lisa Bodei, Kjell Öberg, Berna Polack, Beilei He, Maurizio Mariani, Germo Gericke, Paola Santoro, Jack L. Erion, Laura Ravasi, Eric P. Krenning - European Journal of Nuclear Medicine and Molecular Imaging 2020 被引用: 127

  22. Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate in Patients With Endocrine Gastroenteropancreatic Tumors

    著者: Dik J. Kwekkeboom, Jaap J.M. Teunissen, Willem H. Bakker, P.P.M. Kooij, Wouter W. de Herder, Richard A. Feelders, Casper H.J. van Eijck, Jan-Paul Esser, Boen L. Kam, Eric P. Krenning - Journal of Clinical Oncology 2005 被引用: 659

  23. Effects of therapy with [177Lu-DOTA0, Tyr3]octreotate in patients with paraganglioma, meningioma, small cell lung carcinoma, and melanoma.

    著者: Martijn van Essen, Eric P. Krenning, P.P.M. Kooij, Willem H. Bakker, Richard A. Feelders, Wouter W. de Herder, John G. Wolbers, Dik J. Kwekkeboom - 2006 被引用: 161

  24. Preclinical and first clinical experience with the gastrin-releasing peptide receptor-antagonist [68Ga]SB3 and PET/CT

    著者: Θεοδοσία Μάινα, Hendrik Bergsma, Harshad Kulkarni, Dirk Müeller, David Charalambidis, Eric P. Krenning, Berthold A. Nock, Marion de Jong, Richard P. Baum - European Journal of Nuclear Medicine and Molecular Imaging 2015 被引用: 110